Table 2.

Biological activities of poly-APS and their synthetic analogues.

Compound	AChE Inhibition—Ki (nM) *	Hemolysis (s−1 at 500 nM) **	IC50 for NSCLC (μM) ***
Poly-APS	irreversible inhibition	0.05	4.41
APS3	85	0	3000
APS7	10	0.1	480
APS8	1.875	2.6	478
APS12-2	0.036	5.0	470

NSCLC, non-small cell lung cancer; * [28]; ** [31]; *** [41].